SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Fennec Pharmaceuticals Inc. FENC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Fennec Pharmaceuticals Inc. (FENC) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANEB, AVTE, CSBR, CYT, DBTX, ELYM 等.

FENC 的市值为 $178.63M, 而同行平均市值为 $897.41M. FENC 显著小于其平均同行.

同行与相似公司 — FENC

Anebulo Pharmaceuticals, Inc.

$0.50 -0.04% $20.39M

Aerovate Therapeutics, Inc.

$2.68 0.00% $77.68M

Champions Oncology, Inc.

$5.73 -0.17% $79.57M

Cyteir Therapeutics, Inc.

$3.02 -2.27% $108.71M

Decibel Therapeutics, Inc.

$4.91 -0.81% $123.37M

Eliem Therapeutics, Inc.

$5.11 -0.97% $342.68M

Edgewise Therapeutics, Inc.

$33.16 -2.01% $3.56B

Harmony Biosciences Holdings, Inc.

$29.29 +0.83% $1.69B

Ikena Oncology, Inc.

$17.16 +1,152.55% $718.82M

Disc Medicine, Inc.

$70.48 +2.95% $2.69B

Janux Therapeutics, Inc.

$15.24 +2.28% $927.07M

Keros Therapeutics, Inc.

$11.55 +3.59% $429.91M

其他人也在看

Edgewise Therapeutics, Inc.

Disc Medicine, Inc.

Harmony Biosciences Holdings, Inc.

Olema Pharmaceuticals, Inc.

Janux Therapeutics, Inc.

Ikena Oncology, Inc.

Keros Therapeutics, Inc.

Larimar Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言